| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_371d5e1401b1b6d069500cdd13241b85
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d657e9fd640624251fb1b7458910ef98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_147c327a0cb6282aa46430535f4ba112
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fcd6fafadaa360d81ca23ce6e64922f1 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7084
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-7061
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-70 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5415
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-60 |
| filingDate |
2007-05-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bf24b30a8ea4ef8f2e2de96dd9b5f71e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_642d896b31a4ecf057a7fe138fac5b7b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_14447593035b3a05e919bc8cf2a64f4c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2a39ca35eb3df6592b5d18cfaae7c28c |
| publicationDate |
2009-05-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2009117192-A1 |
| titleOfInvention |
Composition for transdermal absorption and formulation comprising a polymeric matrix formed therefrom |
| abstract |
The inventive composition for transdermal absorption characterized by comprising a nonsteroidal anti-inflammatory drug as an active ingredient together with an alkali metal-containing alcohol derivative as a solubilizing agent for the active ingredient comprises a high concentration of the active ingredient while using only a small amount of the solvent, and a transdermal absorption formulation comprising a polymeric matrix formed from the composition is capable of maximizing the skin absorption of the active ingredient with minimal skin irritation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013060394-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2013060395-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707187-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9707189-B2 |
| priorityDate |
2006-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |